Cell-type dependent response of melanoma cells to aloe emodin

Food and Chemical Toxicology

Volumn 50, Issue 9, 2012, Pages 3181-3189

  Radovic, J ^a   Maksimovic Ivanic, D ^a   Timotijevic, G ^b   Popadic, S ^a   Ramic, Z ^a   Trajkovic, V ^a   Miljkovic, D ^a   Stosic Grujicic, S ^a   Mijatovic, S ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b Belgrade University   (Serbia)

Author keywords

Akt; Aloe emodin; Apoptosis; Differentiation; ERK1 2; Melanoma

Indexed keywords

ALOE EMODIN; CASPASE; CYCLIN D1; CYCLIN D3; DOXORUBICIN; HYDROGEN PEROXIDE; I KAPPA B; INDUCIBLE NITRIC OXIDE SYNTHASE; MELANIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOPHENOL MONOOXYGENASE; PACLITAXEL; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN P53; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL KILLING; CELL SPECIFICITY; CELL STRAIN A375; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG ANTAGONISM; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG SENSITIVITY; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; HUMAN CELL; MELANOCYTE; MELANOGENESIS; MELANOMA; MELANOMA B16; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN AGGREGATION; PROTEIN EXPRESSION; TREATMENT RESPONSE; TUMOR DIFFERENTIATION;

ANIMALS; ANTHRAQUINONES; APOPTOSIS; CELL DIFFERENTIATION; CELL LINE, TUMOR; HUMANS; MAP KINASE SIGNALING SYSTEM; MELANOMA, EXPERIMENTAL; MICE; NITRIC OXIDE SYNTHASE TYPE II; REACTIVE OXYGEN SPECIES;

ALOE;

EID: 84864142459     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.05.047     Document Type: Article

References (54)

1. Acevedo-Duncan M., Russell C., Patel S., Patel R. Aloe-emodin modulates PKC isozymes, inhibits proliferation, and induces apoptosis in U-373MG glioma cells. Int. Immunopharmacol. 2004, 4:1775-1784.
2. Alao J.P. The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention. Mol. Cancer 2007, 6:24.
3. Barnard D.L., Huffman J.H., Morris J.L., Wood S.G., Hughes B.G., Sidwell R.W. Evaluation of the antiviral activity of anthraquinones, anthrones and anthraquinone derivatives against human cytomegalovirus. Antiviral Res. 1992, 17:63-77.
4. Basu S., Ghosh A., Hazra B. Evaluation of the antibacterial activity of Ventilago madraspatana Gaertn. Rubia cordifolia Linn. and Lantana camara Linn.: isolation of emodin and physcion as active antibacterial agents. Phytother. Res. 2005, 19:888-894.
5. Billon N., Terrinoni A., Jolicoeur C., McCarthy A., Richardson W.D., Melino G., Raff M. Roles for p53 and p73 during oligodendrocyte development. Development 2004, 131:1211-1220.
6. Caponigro F., Basile M., de Rosa V., Normanno N. New drugs in cancer therapy, National Tumor Institute, Naples, 17-18 June 2004. Anticancer Drugs 2005, 16:211-221.
7. Chehab N.H., Malikzay A., Stavridi E.S., Halazonetis T.D. Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage. Proc. Natl. Acad. Sci. USA 1999, 96:13777-13782.
8. Chen H.C., Hsieh W.T., Chang W.C., Chung J.G. Aloe-emodin induced in vitro G2/M arrest of cell cycle in human promyelocytic leukemia HL-60 cells. Food Chem. Toxicol. 2004, 42:1251-1257.
9. Chiu T.H., Lai W.W., Hsia T.C., Yang J.S., Lai T.Y., Wu P.P., Ma C.Y., Yeh C.C., Ho C.C., Lu H.F., Wood W.G., Chung J.G. Aloe-emodin induces cell death through S-phase arrest and caspase-dependent pathways in human tongue squamous cancer SCC-4 cells. Anticancer Res. 2009, 29:4503-4511.
10. Delgoffe, G.M., Pollizzi, K.N., Waickman, Heikamp, E., Meyers, D.J., Horton, M.R., Xiao, B., Worley, P.F., Powell, J.D., 2011. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nat. Immunol. 12, 295-303.
11. Demary K., Wong L., Liou J.S., Faller D.V., Spanjaard R.A. Redox control of retinoic acid receptor activity: a novel mechanism for retinoic acid resistance in melanoma cells. Endocrinology 2001, 142:2600-2605.
12. Esmat A.Y., Tomasetto C., Rio M.C. Cytotoxicity of a natural anthraquinone (Aloin) against human breast cancer cell lines with and without ErbB-2: topoisomerase IIalpha coamplification. Cancer Biol. Ther. 2006, 5:97-103.
13. Fenig E., Nordenberg J., Beery E., Sulkes J., Wasserman L. Combined effect of aloe-emodin and chemotherapeutic agents on the proliferation of an adherent variant cell line of Merkel cell carcinoma. Oncol. Rep. 2004, 11:213-217.
14. Fenton T.R., Gout I.T. Functions and regulation of the 70kDa ribosomal S6 kinases. Int. J. Biochem. Cell. Biol. 2011, 43:47-59.
15. Fullbeck M., Huang X., Dumdey R., Frommel C., Dubiel W., Preissner R. Novel curcumin- and emodin-related compounds identified by in silico 2D/3D conformer screening induce apoptosis in tumor cells. BMC Cancer 2005, 5:97.
16. Grimm E.A., Ellerhorst J., Tang C.H., Ekmekcioglu S. Constitutive intracellular production of iNOS and NO in human melanoma: possible role in regulation of growth and resistance to apoptosis. Nitric Oxide 2008, 19:133-137.
17. Gruber J.R., Ohno S., Niles R.M. Increased expression of protein kinase C alpha plays a key role in retinoic acid-induced melanoma differentiation. J. Biol. Chem. 1992, 267:13356-13360.
18. Harhaji L., Mijatovic S., Maksimovic-Ivanic D., Popadic D., Isakovic A., Todorovic-Markovic B., Trajkovic V. Aloe emodin inhibits the cytotoxic action of tumor necrosis factor. Eur. J. Pharmacol. 2007, 568:248-259.
19. Heidemann A., Volkner W., Mengs U. Genotoxicity of aloe emodin in vitro and in vivo. Mutat. Res. 1996, 367:123-133.
20. Hersey P., Zhang X.D. How melanoma cells evade trail-induced apoptosis. Nat. Rev. Cancer 2001, 1:142-150.
21. Hoang M.T., Eichenfield L.F. The rising incidence of melanoma in children and adolescents. Dermatol. Nurs. 2000, 12:188-189.
22. Huang H.C., Chang J.H., Tung S.F., Wu R.T., Foegh M.L., Chu S.H. Immunosuppressive effect of emodin, a free radical generator. Eur. J. Pharmacol. 1992, 211:359-364.
23. Huang H.C., Lee C.R., Chao P.D., Chen C.C., Chu S.H. Vasorelaxant effect of emodin, an anthraquinone from a Chinese herb. Eur. J. Pharmacol. 1991, 205:289-294.
24. Huang Q., Shen H.M., Ong C.N. Emodin inhibits tumor cell migration through suppression of the phosphatidylinositol 3-kinase-Cdc42/Rac1 pathway. Cell. Mol. Life Sci. 2005, 62:1167-1175.
25. Kang H.K., Suh J.H., Lee J.J., Yoon S.H., Hyun J.W., Choi S.W., Choi J.Y., Ryu K.H., Chung M.H. Induction of the differentiation of HL-60 promyelocytic leukemia cells by l-ascorbic acid. Free Radic. Res. 2003, 37:773-779.
26. Kim M.S., Park M.J., Kim S.J., Lee C.H., Yoo H., Shin S.H., Song E.S., Lee S.H. Emodin suppresses hyaluronic acid-induced MMP-9 secretion and invasion of glioma cells. Int. J. Oncol. 2005, 27:839-846.
27. Kim Y.M., Lee C.H., Kim H.G., Lee H.S. Anthraquinones isolated from Cassia tora (Leguminosae) seed show an antifungal property against phytopathogenic fungi. J. Agric. Food Chem. 2004, 52:6096-6100.
28. Kumar A., Dhawan S., Aggarwal B.B. Emodin (3-methyl-1, 6, 8-trihydroxyanthraquinone) inhibits TNF-induced NF-kappaB activation, IkappaB degradation, and expression of cell surface adhesion proteins in human vascular endothelial cells. Oncogene 1998, 17:913-918.
29. Kuo P.L., Lin T.C., Lin C.C. The antiproliferative activity of aloe-emodin is through p53-dependent and p21-dependent apoptotic pathway in human hepatoma cell lines. Life Sci. 2002, 71:1879-1892.
30. Lee H.Z., Hsu S.L., Liu M.C., Wu C.H. Effects and mechanisms of aloe-emodin on cell death in human lung squamous cell carcinoma. Eur. J. Pharmacol. 2001, 431:287-295.
31. Lee H.Z., Lin C.J., Yang W.H., Leung W.C., Chang S.P. Aloe-emodin induced DNA damage through generation of reactive oxygen species in human lung carcinoma cells. Cancer Lett. 2006, 239:55-63.
32. Lee H.Z., Wu C.H., Chang S.P. Release of nucleophosmin from the nucleus: Involvement in aloe-emodin-induced human lung non small carcinoma cell apoptosis. Int. J. Cancer 2005, 113:971-976.
33. Lin J.G., Chen G.W., Li T.M., Chouh S.T., Tan T.W., Chung J.G. Aloe-emodin induces apoptosis in T24 human bladder cancer cells through the p53 dependent apoptotic pathway. J. Urol. 2006, 175:343-347.
34. Maksimovic-Ivanic D., Mijatovi S., Harhaji L., Miljkovic D., Dabideen D., Fan Cheng K., Mangano K., Malaponte G., Al-Abed Y., Libra M., Garotta G., Nicoletti F., Stosic-Grujicic S. Anticancer properties of the novel nitric oxide-donating compound (S, R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide in vitro and in vivo. Mol. Cancer Ther. 2008, 7:510-520.
35. Mijatovic S., Maksimovic-Ivanic D., Mojic M., Timotijevic G., Miljkovic D., Mangano K., Donia M., Di Cataldo A., Al-Abed Y., Cheng K.F., Stosic-Grujicic S., Nicoletti F. Cytotoxic and immune-sensitizing properties of nitric oxide-modified Saquinavir in iNOS-positive human melanoma cells. J. Cell. Physiol. 2011, 226:1803-1812.
36. Mijatovic S., Maksimovic-Ivanic D., Radovic J., Miljkovic D., Kaludjerovic G.N., Sabo T.J., Trajkovic V. Aloe emodin decreases the ERK-dependent anticancer activity of cisplatin. Cell. Mol. Life Sci. 2005, 62:1275-1282.
37. Mijatovic S., Maksimovic-Ivanic D., Radovic J., Miljkovic Dj., Harhaji Lj, Vuckovic O., Stosic-Grujicic S., Mostarica Stojkovic M., Trajkovic V. Anti-glioma action of aloe emodin: the role of ERK inhibition. Cell. Mol. Life Sci. 2005, 62:589-598.
38. Mijatovic S., Maksimovic-Ivanic D., Radovic J., Popadic D., Momcilovic M., Harhaji Lj., Miljkovic D., Trajkovic V. Aloe-emodin prevents cytokine-induced tumor cell death: the inhibition of auto-toxic nitric oxide release as a potential mechanism. Cell. Mol. Life Sci. 2004, 61:1805-1815.
39. Mueller S.O., Stopper H., Dekant W. Biotransformation of the anthraquinones emodin and chrysophanol by cytochrome P450 enzymes. Bioactivation to genotoxic metabolites. Drug Metab. Dispos. 1998, 26:540-546.
40. Pecere T., Gazzola M.V., Mucignat C., Parolin C., Vecchia F.D., Cavaggioni A., Basso G., Diaspro A., Salvato B., Carli M., Palu G. Aloe-emodin is a new type of anticancer agent with selective activity against neuroectodermal tumors. Cancer Res. 2000, 60:2800-2804.
41. Russo A.E., Torrisi E., Bevelacqua Y., Perrotta R., Libra M., McCubrey J.A., Spandidos D.A., Stivala F., Malaponte G. Melanoma: molecular pathogenesis and emerging target therapies. Int. J. Oncol. 2009, 34:1481-1489.
42. Steinbeck M.J., Kim J.K., Trudeau M.J., Hauschka P.V., Karnovsky M.J. Involvement of hydrogen peroxide in the differentiation of clonal HD-11EM cells into osteoclast-like cells. J. Cell. Physiol. 1998, 176:574-587.
43. Su Y.T., Chang H.L., Shyue S.K., Hsu S.L. Emodin induces apoptosis in human lung adenocarcinoma cells through a reactive oxygen species-dependent mitochondrial signaling pathway. Biochem. Pharmacol. 2005, 70:229-241.
44. Tabolacci C., Lentini A., Mattioli P., Provenzano B., Oliverio S., Carlomosti F., Beninati S. Antitumor properties of aloe-emodin and induction of transglutaminase 2 activity in B16-F10 melanoma cells. Life Sci. 2010, 87:316-324.
45. Tang C.H., Grimm E.A. Depletion of endogenous nitric oxide enhances cisplatin-induced apoptosis in a p53-dependent manner in melanoma cell lines. J. Biol. Chem. 2004, 279:288-298.
46. Tokumoto Y.M., Durand B., Raff M.C. An analysis of the early events when oligodendrocyte precursor cells are triggered to differentiate by thyroid hormone, retinoic acid, or PDGF withdrawal. Dev. Biol. 1999, 213:327-339.
47. Ullmannová V., Stöckbauer P., Hradcová M., Soucek J., Haskovec C. Relationship between cyclin D1 and p21(Waf1/Cip1) during differentiation of human myeloid leukemia cell lines. Leuk. Res. 2003, 27:1115-1123.
48. Wasserman L., Avigad S., Beery E., Nordenberg J., Fenig E. The effect of aloe emodin on the proliferation of a new merkel carcinoma cell line. Am. J. Dermatopathol. 2002, 24:17-22.
49. Wu X., Hasinoff B.B. The antitumor anthracyclines doxorubicin and daunorubicin do not inhibit cell growth through the formation of iron-mediated reactive oxygen species. Anticancer Drugs 2005, 16:93-99.
50. 2. Am. J. Physiol. Cell. Physiol. 2009, 296:C711-C723.
51. Yagi T., Yamauchi K., Kuwano S. The synergistic purgative action of aloe-emodin anthrone and rhein anthrone in mice. synergism in large intestinal propulsion and water secretion. J. Pharm. Pharmacol. 1997, 49:22-25.
52. Yang J., Li H., Chen Y.Y., Wang X.J., Shi G.Y., Hu Q.S., Kang X.L., Lu Y., Tang X.M., Guo Q.S., Yi J. Anthraquinones sensitize tumor cells to arsenic cytotoxicity in vitro and in vivo via reactive oxygen species-mediated dual regulation of apoptosis. Free. Radic. Biol. Med. 2004, 37:2027-2041.
53. Yeh F.T., Wu C.H., Lee H.Z. Signalling pathway for aloe-emodin-induced apoptosis in human H460 lung nonsmall carcinoma cell. Int. J. Cancer 2003, 106:26-33.
54. Zhang L., Lau Y.K., Xia W., Hortobagyi G.N., Hung M.C. Tyrosine kinase inhibitor emodin suppresses growth of HER-2/neu-overexpressing breast cancer cells in athymic mice and sensitizes these cells to the inhibitory effect of paclitaxel. Clin. Cancer Res. 1999, 5:343-353.